
Allergy Immunotherapy Market Report 2023-2033
Description
Allergy Immunotherapy Market Report 2023-2033
The Allergy Immunotherapy Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Significant advancements in allergy immunotherapy techniques have propelled the industry forward. The introduction of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) has expanded treatment options, making immunotherapy more accessible and convenient for patients. Additionally, the development of allergen-specific immunotherapies and modified formulations, such as recombinant allergens and adjuvants, has improved treatment efficacy and safety.
Rising healthcare expenditure, particularly in developed countries, has contributed to the growth of the allergy immunotherapy industry. As individuals and healthcare systems prioritize preventive care and long-term management of chronic conditions, allergy immunotherapy has gained recognition as a cost-effective approach. This has fuelled investments in research, innovation, and infrastructure to meet the growing demand.
What Questions Should You Ask before Buying a Market Research Report?
- How is the allergy immunotherapy market evolving?
- What is driving and restraining the allergy immunotherapy market?
- How will each allergy immunotherapy submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each allergy immunotherapy submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading allergy immunotherapy markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the allergy immunotherapy projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of
- Is there a greater need for product commercialisation to further scale the allergy immunotherapy market?
- Where is the allergy immunotherapy market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
- Our 187-page report provides 89 tables and 120 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Treatment Type
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
- Allergic Rhinitis
- Asthma
- Others
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
North America
- U.S.
- Canada
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC
- South Africa
- Rest of MEA
Leading companies and the potential for market growth
- Aimmune Therapeutics
- ALK-Abelló A/S
- Adamis Pharmaceuticals Corporation
- Allergy Therapeutics
- Allergopharma
- DBV Technologies
- DESENTUM OY
- HAL Allergy B.V.
- HISHOH Biopharma
- HollisterStier Allergy (Jubilant Pharma Company)
- LETI Pharma
- Stallergenes Greer
How will the Allergy Immunotherapy Market, 2023 to 2033 report help you?
In summary, our 180+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Allergy Immunotherapy Market, 2023 to 2033 Market, with forecasts for treatment type, allergy type, and distribution channel each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Allergy Immunotherapy Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 12 of the major companies involved in the Allergy Immunotherapy Market, 2023 to 2033.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Allergy Immunotherapy Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..
The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.
Table of Contents
187 Pages
- 1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Allergy Immunotherapy Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Reports
- 1.10 About
- 2 Executive Summary
- 3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Increasing Burden of Various Types of Allergies
- 3.2.1.2 Launch of New Sublingual Immunotherapies in Emerging Economies
- 3.2.1.3 Increasing Allergic Rhinitis and Asthma Cases
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Lack of Awareness about Allergy and Treatments
- 3.2.2.2 Drawbacks Associated with the use of Allergy Immunotherapy
- 3.2.3 Market Opportunities
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter’s Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Buyer Power of Buyers
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat from Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
- 4 Allergy Immunotherapy Market Analysis by Treatment Type
- 4.1 Key Findings
- 4.2 Treatment Type Segment: Market Attractiveness Index
- 4.3 Allergy Immunotherapy Market Size Estimation and Forecast by Treatment Type
- 4.4 Subcutaneous Immunotherapy (SCIT)
- 4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
- 4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.5 Sublingual Immunotherapy (SLIT)
- 4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
- 4.5.2 Market Share by Region, 2023 & 2033 (%)
- 5 Allergy Immunotherapy Market Analysis by Allergy Type
- 5.1 Key Findings
- 5.2 Allergy Type Segment: Market Attractiveness Index
- 5.3 Allergy Immunotherapy Market Size Estimation and Forecast by Allergy Type
- 5.4 Allergic Rhinitis
- 5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
- 5.4.2 Market Share by Region, 2023 & 2033 (%)
- 5.5 Asthma
- 5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
- 5.5.2 Market Share by Region, 2023 & 2033 (%)
- 5.6 Others
- 5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
- 5.6.2 Market Share by Region, 2023 & 2033 (%)
- 6 Allergy Immunotherapy Market Analysis by Distribution Channel
- 6.1 Key Findings
- 6.2 Distribution Channel Segment: Market Attractiveness Index
- 6.3 Allergy Immunotherapy Market Size Estimation and Forecast by Distribution Channel
- 6.4 Hospital Pharmacy
- 6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
- 6.4.2 Market Share by Region, 2023 & 2033 (%)
- 6.5 Retail Pharmacy
- 6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
- 6.5.2 Market Share by Region, 2023 & 2033 (%)
- 6.6 Online Pharmacy
- 6.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
- 6.6.2 Market Share by Region, 2023 & 2033 (%)
- 7 Allergy Immunotherapy Market Analysis by Region
- 7.1 Key Findings
- 7.2 Regional Market Size Estimation and Forecast
- 8 North America Allergy Immunotherapy Market Analysis
- 8.1 Key Findings
- 8.2 North America Allergy Immunotherapy Market Attractiveness Index
- 8.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
- 8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
- 8.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
- 8.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
- 8.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
- 8.8 U.S. Allergy Immunotherapy Market Analysis
- 8.9 Canada Allergy Immunotherapy Market Analysis
- 9 Europe Allergy Immunotherapy Market Analysis
- 9.1 Key Findings
- 9.2 Europe Allergy Immunotherapy Market Attractiveness Index
- 9.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
- 9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
- 9.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
- 9.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
- 9.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
- 9.8 Germany Allergy Immunotherapy Market Analysis
- 9.9 UK Allergy Immunotherapy Market Analysis
- 9.10 France Allergy Immunotherapy Market Analysis
- 9.11 Italy Allergy Immunotherapy Market Analysis
- 9.12 Spain Allergy Immunotherapy Market Analysis
- 9.13 Russia Allergy Immunotherapy Market Analysis
- 9.14 Rest of Europe Allergy Immunotherapy Market Analysis
- 10 Asia Pacific Allergy Immunotherapy Market Analysis
- 10.1 Key Findings
- 10.2 Asia Pacific Allergy Immunotherapy Market Attractiveness Index
- 10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
- 10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
- 10.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
- 10.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
- 10.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
- 10.8 Japan Allergy Immunotherapy Market Analysis
- 10.9 China Allergy Immunotherapy Market Analysis
- 10.10 India Allergy Immunotherapy Market Analysis
- 10.11 Australia Allergy Immunotherapy Market Analysis
- 10.12 South Korea Allergy Immunotherapy Market Analysis
- 10.13 South-East Asia Allergy Immunotherapy Market Analysis
- 10.14 Rest of Asia Pacific Allergy Immunotherapy Market Analysis
- 11 Latin America Allergy Immunotherapy Market Analysis
- 11.1 Key Findings
- 11.2 Latin America Allergy Immunotherapy Market Attractiveness Index
- 11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
- 11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
- 11.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
- 11.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
- 11.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
- 11.8 Brazil Allergy Immunotherapy Market Analysis
- 11.9 Mexico Allergy Immunotherapy Market Analysis
- 11.10 Argentina Allergy Immunotherapy Market Analysis
- 11.11 Colombia Allergy Immunotherapy Market Analysis
- 11.12 Rest of Latin America Allergy Immunotherapy Market Analysis
- 12 MEA Allergy Immunotherapy Market Analysis
- 12.1 Key Findings
- 12.2 MEA Allergy Immunotherapy Market Attractiveness Index
- 12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
- 12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
- 12.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
- 12.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
- 12.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
- 12.8 GCC Allergy Immunotherapy Market Analysis
- 12.9 South Africa Allergy Immunotherapy Market Analysis
- 12.10 Rest of MEA Allergy Immunotherapy Market Analysis
- 13 Company Profiles
- 13.1 Aimmune Therapeutics
- 13.1.1 Company Snapshot
- 13.1.2 Company Overview
- 13.1.3 Financial Analysis
- 13.1.4 Product Benchmarking
- 13.2 ALK-Abelló A/S
- 13.2.1 Company Snapshot
- 13.2.2 Company Overview
- 13.2.3 Product Benchmarking
- 13.3 Adamis Pharmaceuticals Corporation
- 13.3.1 Company Snapshot
- 13.3.2 Company Overview
- 13.3.3 Financial Analysis
- 13.3.3.1 Net Revenue, 2017-2022
- 13.3.3.2 R&D, 2017-2022
- 13.3.4 Product Benchmarking
- 13.3.5 Strategic Outlook
- 13.4 Allergy Therapeutics
- 13.4.1 Company Snapshot
- 13.4.2 Company Overview
- 13.4.3 Financial Analysis
- 13.4.3.1 Net Revenue, 2017-2022
- 13.4.3.2 R&D, 2017-2022
- 13.4.4 Product Benchmarking
- 13.5 Allergopharma
- 13.5.1 Company Snapshot
- 13.5.2 Company Overview
- 13.5.3 Product Benchmarking
- 13.6 DVB Technologies SA
- 13.6.1 Company Snapshot
- 13.6.2 Company Overview
- 13.6.3 Financial Analysis
- 13.6.3.1 Net Revenue, 2017-2022
- 13.6.3.2 R&D, 2017-2022
- 13.6.4 Product Benchmarking
- 13.6.5 Strategic Outlook
- 13.7 DESENTUM OY
- 13.7.1 Company Snapshot
- 13.7.2 Company Overview
- 13.7.3 Product Benchmarking
- 13.8 HAL Allergy Group
- 13.8.1 Company Snapshot
- 13.8.2 Company Overview
- 13.8.3 Product Benchmarking
- 13.9 HISHOH Biopharma
- 13.9.1 Company Snapshot
- 13.9.2 Company Overview
- 13.9.3 Product Benchmarking
- 13.9.4 Strategic Outlook
- 13.10 HollisterStier Allergy (Jubilant Pharma Company)
- 13.10.1 Company Snapshot
- 13.10.2 Company Overview
- 13.10.3 Product Benchmarking
- 13.11 LETIPharma
- 13.11.1 Company Snapshot
- 13.11.2 Company Overview
- 13.11.3 Product Benchmarking
- 13.12 Stallergenes Greer
- 13.12.1 Company Snapshot
- 13.12.2 Company Overview
- 13.12.3 Product Benchmarking
- 13.12.4 Strategic Outlook
- 14 Conclusion and Recommendations
- 14.1 Concluding Remarks from
- 14.2 Recommendations for Market Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.